logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

CH BIOTECH SER (08037): He Xun Resigns as Executive Director

date
17:32 30/04/2026
avatar
GMT Eight
Chinese Biotechnology Services (08037) announced that Mr. He Xun has resigned as an executive director due to the need to devote more energy to handle other business. The resignation will take effect from May 1, 2026.
CH BIOTECH SER (08037) announced that Mr. He Xun has submitted his resignation as an executive director, effective from May 1, 2026, as he needs to allocate more time to handle other business matters.
Related Articles
HK Stock
BAY AREA DEV(00737) subsidiary Guangzhou-Xi Joint Venture signed a digital transformation construction contract.
China Stock
Hunan Haili Chemical Industry (600731.SH) plans to participate in the public bidding for 51% equity stake in Fengle Agricultural Chemical Company.
HK Stock
HYGEIA HEALTH (06078) spent 2.9984 million Hong Kong dollars to repurchase 26,060 shares on April 30th.
BAY AREA DEV(00737) subsidiary Guangzhou-Xi Joint Venture signed a digital transformation construction contract.
HK Stock
Hunan Haili Chemical Industry (600731.SH) plans to participate in the public bidding for 51% equity stake in Fengle Agricultural Chemical Company.
China Stock
HYGEIA HEALTH (06078) spent 2.9984 million Hong Kong dollars to repurchase 26,060 shares on April 30th.
HK Stock
RECOMMEND
China Leads as Humanoid Robotics Reach Commercial Turning Point
China Leads as Humanoid Robotics Reach Commercial Turning Point
icon
29/04/2026
AI Disruption Reshapes US Equity Valuations as Terminal Value Volatility Takes Center Stage
AI Disruption Reshapes US Equity Valuations as Terminal Value Volatility Takes Center Stage
icon
29/04/2026
Political Bureau Meeting Sets Tone for Growth Eight Key Takeaways on Property Capital Markets and Monetary Policy
Political Bureau Meeting Sets Tone for Growth Eight Key Takeaways on Property Capital Markets and Monetary Policy
icon
29/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.